Cargando…
OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment
Rationale: The resistance of pancreatic ductal adenocarcinoma (PDAC) to immunotherapies is caused by the immunosuppressive tumor microenvironment (TME) and dense extracellular matrix. Currently, the efficacy of an isolated strategy targeting stromal desmoplasia or immune cells has been met with limi...
Autores principales: | Liu, Shiyu, Li, Fan, Ma, Qiongqiong, Du, Mingjuan, Wang, Haoran, Zhu, Yiping, Deng, Li, Gao, Wenrui, Wang, Chunlei, Liu, Yanqin, Zhao, Zhuoqian, Liu, Huanzhen, Wang, Ruikun, Tian, Yujie, Hu, Manli, Wan, Yajuan, Lu, Wenyi, Zhang, Meng, Zhao, Mingfeng, Cao, Youjia, Zhang, Hongkai, Wang, Wei, Wang, Hui, Wang, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405835/ https://www.ncbi.nlm.nih.gov/pubmed/37554264 http://dx.doi.org/10.7150/thno.83495 |
Ejemplares similares
-
Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer
por: Liu, Shiyu, et al.
Publicado: (2023) -
CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model
por: Wang, Ruikun, et al.
Publicado: (2022) -
Construction of an IL12 and CXCL11 armed oncolytic herpes simplex virus using the CRISPR/Cas9 system for colon cancer treatment
por: Zhang, Nianchao, et al.
Publicado: (2022) -
High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics
por: Wang, Yuan, et al.
Publicado: (2021) -
A general Fc engineering platform for the next generation of antibody therapeutics
por: Chen, Da, et al.
Publicado: (2021)